Synbio Technologies provides a one stop solution to recombinant antibody research. We can accurately obtain hybridoma sequences from any species or isotypes. With the combination of our proprietary Syno® gene synthesis platform and high throughput antibody manufacturing, your final recombinant antibody products will be delivered to support your scientific research in a timely and cost effective manner.
From Hybridoma Sequencing to Recombinant Antibody Process
*Customers will need to submit hybridoma cell samples (>1×106 cells) and indicate the subtype of your monoclonal antibody. For more information please contact us at email@example.com.